Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Brennan, Daniel C
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26
KOAR, NCT03326076: Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry	Active, not recruiting	N/A	4000	US	Donor-derived cell-free DNA (AlloSure®), Standard care, Peripheral blood gene expression profiling (AlloMap Kidney), Analytic platform (IBox)	CareDx	Kidney Transplant Rejection	06/25	12/25
Arksarapuk, Jittirat
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26
Carter, Katherine R
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/25	12/26